Rock on third stage trial of Oxford vaccine in India, this is the reason

New delhi date. 10 September 2020, Thursday

The trial of the Oxford Corona vaccine in India is currently on hold, citing safety reasons.

The trial will remain on hold until further notice from the Drug Controller General of India. The results of the initial trial of the Oxford vaccine were encouraging. However, the trial was halted in Britain and the United States after a patient fell ill in Britain. The trial of the vaccine will continue in India, it was said.

However, the Drugs Control General of India has issued a notice to the Serum Institute asking why you have not informed us about the results of the ongoing trial in another country.

The Oxford vaccine is being tested at 17 locations in India. However, the Serum Institute has now decided to suspend the trial after receiving a notice. .

It has been found that during this trial in Britain, a patient was diagnosed with a syndrome of affecting the spinal cord due to the effect of the drug.

Vaccine experts in India say that sometimes patients get sick and even die during the trial. In these circumstances, the trial needs to be stopped.

The Trial Jetta and Safety Monitoring Board in India will now monitor the situation and take a further decision based on its recommendations.